TARDIO JASON (Chief Commercial Officer) received a stock award from OVID THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/26/2024ACC: 0001209191-24-003972
Officer· Chief Commercial Officer
Since Nov 2019
+196.88K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
196.88K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+28.13K
Price / share
—
Trade value
—
% of position
New position
2/22/2024
0.00→28.13K
Total
Net shares
+28.13K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/22/2024 | A · Award | +28.13K | — | — | New position | 0.00 | 28.13K |
| Total | +28.13K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
168.75K shares
Shares
+168.75K
Strike price
3.68
Held after
168.75K
Exercisable
—
2/22/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock168.75K shares | 2/22/2024 | A · Award | +168.75K | 3.68 | — | 168.75K |